Key points are not available for this paper at this time.
Women with benign heavy menstrual bleeding have the choice of a number of medical treatment options to reduce their blood loss and improve quality of life. The role of the clinician is to provide information to facilitate women in making an appropriate choice. Unfortunately, many options can be associated with hormonal side effects, prevention of fertility and lack of efficacy, leading to discontinuation and progression to surgical interventions. Herein, we discuss the various options currently available to women, including antifibrinolytics, nonsteroidal anti-inflammatory preparations, oral contraceptive pills and oral, injectable and intrauterine progestogens. In addition, we describe the more novel option of selective progesterone receptor modulators and their current benefits and limitations.
Building similarity graph...
Analyzing shared references across papers
Loading...
Jacqueline A. Maybin
Hilary Critchley
Women s Health
University of Edinburgh
MRC Centre for Reproductive Health
Building similarity graph...
Analyzing shared references across papers
Loading...
Maybin et al. (Wed,) studied this question.
www.synapsesocial.com/papers/69ff487f948103423c851598 — DOI: https://doi.org/10.2217/whe.15.100
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: